Schonfeld Strategic Advisors LLC Oramed Pharmaceuticals Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.12 - $4.47 $27,348 - $57,663	12,900 Added 74.14%	30,300 $108,000
Q1 2023 May 15, 2023	BUY	$1.93 - $13.1 $33,582 - $227,940	17,400 New	17,400 $37,000
Q3 2022 Nov 14, 2022	SELL	$4.6 - $9.91 $294,400 - $634,240	-64,000 Reduced 79.6%	16,400 $106,000
Q2 2022 Aug 15, 2022	BUY	$3.72 - $9.0 $250,728 - $606,600	67,400 Added 518.46%	80,400 $368,000
Q1 2022 May 16, 2022	BUY	$8.19 - $13.89 $106,470 - $180,570	13,000 New	13,000 $112,000

6.37M

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $91.2M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.